About this trial
The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with the participant's second concussion clinical visit, typically (but not limited to) between 21-31 days from V1.
Eligibility criteria
Qualifiers
50 years of age or older
Diagnosed concussion within the last 4 days - 12 months
Must be recruited at their initial concussion appointment
Ability to read/write to complete study assessments/testing
Disqualifiers
Diagnosed major psychiatric disorders other than depression/anxiety (e.g., schizophrenia)
Diagnosed with moderate to severe brain injury or past brain surgery/malformations
Trial design
Treatments tested in this trial
- Behavioral Control
- Targeted Intervention